Table 1 Patient baseline data
Before match | |||
|---|---|---|---|
Jejunostomy group (n = 1044) | Nasojejunal group (n = 356) | P value | |
Sex (Male) | 817 (78.3%) | 272 (76.4%) | 0.514 |
Age (y) | 61.8 ± 16.5 | 63.5 ± 14.6 | 0.084 |
Tumor location | < 0.001 | ||
Superior segment | 0 (0.0%) | 201 (56.5%) | |
Middle segment | 621 (59.5%) | 147 (41.3%) | |
Inferior segment | 423 (40.5%) | 8 (2.2%) | |
Preoperative ASA staging | 0.085 | ||
I | 176 (16.9%) | 53 (14.9%) | |
II | 725 (69.4%) | 237 (66.6%) | |
III | 143 (13.7%) | 66 (18.5%) | |
Postoperative TNM staging | |||
Postoperative T staging | 0.172 | ||
T1 | 103 (9.8%) | 35 (9.8%) | |
T2 | 216 (20.7%) | 64 (18.0%) | |
T3 | 624 (59.8%) | 208 (58.4%) | |
T4 | 101 (9.7%) | 49 (13.8%) | |
Postoperative N staging | 0.127 | ||
N0 | 208 (19.9%) | 54 (15.2%) | |
N1 | 626 (60.0%) | 228 (64.0%) | |
N2 | 210 (20.1%) | 74 (20.8%) | |
Pathological G staging | 0.649 | ||
G1 | 208 (19.9%) | 71 (19.9%) | |
G2 | 731 (70.0%) | 243 (68.3%) | |
G3 | 105 (10.1%) | 42 (11.8%) | |
Previous history of abdominal surgery | 98 (9.4%) | 31 (8.7%) | 0.782 |